Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Short description of key information on bioaccumulation potential result: 
Toxicokinetic in vitro
Incubation in 0.1 M HCl, rat plasma or rat liver homogenate at 37°C for up to 4 hours: no detectable formation of EDTA (GLP; BASF 1995)
Considerations based on physico-chemical properties
- inhalative exposure is considered as unlikely
- potential for a dermal absorption is considered as very low
- very low bioaccumulation potential is assumed

Key value for chemical safety assessment

Additional information

In a toxicokinetic study according to GLP requirements, the degradation of the test substance Keroflux ES 3241 and the formation of EDTA was determined after incubation either in 0.1 M HCl, rat plasma or rat liver homogenate in order to simulate conditions in stomach, blood and liver (BASF AG 1995).

Incubation of Keroflux ES 3241 in 0.1 M HCl 1 mg/ml at 37°C for up to 4 hours simulating conditions in the stomach lead to a small decrease of Keroflux ES 3241 concentration in the incubation medium (maximum 6% after 4 hrs of incubation). With respect to the variation of the results at 1 and 2 h, this decrease is not significant. No EDTA could be detected considering a detection limit of about 2 µg/ml.

Incubation of Keroflux ES 3241 in rat plasma at 37°C for up to 4 hours lead to a decrease of Keroflux ES 3241 concentration in the incubation medium by 24 % after 4 hrs of incubation (10% after 2 hrs of incubation). However, no EDTA could be detected above a detection limit of about 2 µg/ml.

Considerations based on physico-chemical properties:

Keroflux ES 3241 has a very low vapour pressure (< 0.0006 Pa at 20°C, see IUCLID chapter 4.6), therefore an inhalative exposure is considered as unlikely. Additionally, the potential for a dermal absorption is considered as very low due to the high molecular weight (between 1630 and 2310 g/mol) and the low solubility in water and in octanol (see IUCLID chapter 4.7). Furthermore, a very low bioaccumulation potential is assumed based on a calculated log Pow range of 41 to 67 (see IUCLID chapter 5.3.1).